Scaffold_Type,Molecule_ID,Best_Affinity,ADME_Score,Key_Advantage,Development_Status,Clinical_Readiness
2-Hydroxypyridine,1,-7.9,11.66,Perfect ADME + Key Interactions,LEAD COMPOUND,Immediate
2-Methylpyridine,9,-8.4,9.84,Perfect N positioning,Highest Affinity,High_Potency_Track
4-Fluoropyrimidine,5,-8.1,10.84,Dual N + fluorine,Excellent Balance,Secondary_Lead
4-Methylimidazole,3,-8.0,7.08,NH donor capability,Good Performance,Backup_Option
3-Fluoropyridine,8,-7.7,9.34,Aromatic stacking,High Priority,Development_Candidate
2-Cyanopyridine,7,-7.6,8.12,Nitrile group benefits,Medium Priority,Study_Compound
2-Methylpyrimidine,4,-7.5,8.45,Pyrimidine electronics,Low Priority,Research_Interest
4-Methylpyrimidine,2,-7.3,7.23,Simple scaffold,Low Priority,Basic_Activity
4-Fluoropyridine,6,-7.1,6.89,Fluorine optimization,Low Priority,Limited_Potential
4-Fluorobenzene,10,-7.1,6.78,Basic scaffold,Low Priority,Threshold
